NCT07271836 PLACE Trial: Preserving Long-Acting Contraception Through Education
| NCT ID | NCT07271836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pakistan Institute of Medical Sciences |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2025-12-15 |
| Primary Completion | 2026-08 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Study Overview Summary This randomized controlled trial will evaluate the effectiveness of structured counseling in improving the continuation rates of long-acting reversible contraception (LARC) among women in Islamabad, Pakistan, who present to family planning clinics for early removal of their contraception devices (copper-T IUD or Jadelle implant). The study, starting December 15, 2025, will recruit women from three federal government-approved clinics. The trial will randomly assign participants to either an intervention group, where they will receive culturally sensitive counseling to encourage continued use of LARC, or a control group, where contraception will be removed upon client request without counseling. The goal is to determine if structured counseling can increase the likelihood of women continuing their LARC method.
Eligibility Criteria
Inclusion Criteria: * Women presenting at the clinics exclusively for removal of a copper-T IUD or Jadelle subdermal implant within 2 years of use and within the first 2 months of the study. Exclusion Criteria: * Women not wishing to participate or unable to provide informed consent.